These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical significance of circulating immune complex assay in patients with systemic lupus erythematosus. Phi NC; Chien DK; Chinh DV; Péter G Acta Med Hung; 1989; 46(2-3):109-20. PubMed ID: 2812955 [TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes and the complements system in lupus nephropathy. Serban MG Rom J Intern Med; 1992; 30(2):119-25. PubMed ID: 1496264 [TBL] [Abstract][Full Text] [Related]
9. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus. Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422 [TBL] [Abstract][Full Text] [Related]
10. [Effect of the method of extracorporeal heparin precipitation of plasma proteins (selective plasmapheresis) on the level of immune complexes in the blood]. Savchenko VG; Margulis EIa; Vasiliev SA; Gorodetskiĭ VM; Ryzhko VV Ter Arkh; 1985; 57(7):102-7. PubMed ID: 2931844 [TBL] [Abstract][Full Text] [Related]
11. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Jones JV; Cumming RH; Bacon PA; Evers J; Fraser ID; Bothamley J; Tribe CR; Davis P; Hughes GR Q J Med; 1979 Oct; 48(192):555-76. PubMed ID: 317156 [TBL] [Abstract][Full Text] [Related]
13. Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes. Morimoto C; Sano H; Abe T; Homma M; Steinberg AD J Immunol; 1982 Nov; 129(5):1960-5. PubMed ID: 7119438 [TBL] [Abstract][Full Text] [Related]
14. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus. Adu D; Williams DG Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265 [TBL] [Abstract][Full Text] [Related]
15. [Value of plasma exchange in neurologic complications of acute disseminated lupus erythematosus in children]. Couillault G; Gouyon JB; Chalopin JM; Rifle G; Nivelon JL Arch Fr Pediatr; 1985 Jan; 42(1):41-3. PubMed ID: 3872647 [TBL] [Abstract][Full Text] [Related]
17. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus. Davis P; Cumming RH; Verrier-Jones J Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447 [TBL] [Abstract][Full Text] [Related]
18. [The results of 5 years' use of a method for heparin cryoprecipitation of plasma proteins (selective plasmapheresis) in patients with an immune-complex pathology]. Margulis EIa; Savchenko VG Ter Arkh; 1989; 61(7):65-9. PubMed ID: 2531473 [TBL] [Abstract][Full Text] [Related]
19. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease. Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475 [TBL] [Abstract][Full Text] [Related]
20. [Combined use of impact doses of 6-methylprednisolone and cyclophosphamide in patients with systemic lupus erythematosus]. Solov'ev SK; Ivanova MM; Nasonov EL; Anan'eva LP; Sazhina EG Ter Arkh; 1985; 57(8):7-12. PubMed ID: 2933841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]